United States · Investor

Oxford Finance LLC

Last cheque observed Dec 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietPrivate equity

SeedSeries ASeries BWell-beingTelehealthHealth-tech

Cheques on record
0%of best year0cheques in 12 months, 53 on record
Since the last cheque3981days00hrs00min00sec
Median round$15MCheque size, as they say$5.0M – $350MRounds led0 of 53Sole investor23 roundsExits9 from the portfolioMostly inUnited States, 98%
Pitch Oxford Finance LLC

Oxford Finance LLC highlights

  1. 01

    53 rounds on record

  2. 02

    Mostly Debt and Venture: 94% of its rounds

  3. 03

    Sole investor in 23 rounds, median $12M

  4. 04

    9 exits from the portfolio

What they do

Oxford Finance delivers flexible financial solutions to companies worldwide across multiple sectors, including life sciences, healthcare, business services and software & technology.From their own website
Type
Private equity (from a list, unverified)
Cheque size
$5.0M – $350M as they say
Stages
SeedSeries ASeries BGrowth
Sectors
Well-beingTelehealthHealth-tech
Based in
Alexandria, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first53 appearances

  1. 2015

    12 rounds

  2. Dec
    MDRejuvenaDebt · US$3.0MSole investor
  3. Nov
    Zyga TechnologyDebt · US$15MWith 1 other
  4. Nov
    Continuum HealthcareDebt · US$14MSole investor
  5. Nov
    Venus ConceptDebt · CA$20MSole investor
  6. Aug
    Ocera TherapeuticsDebt · US$20MWith 1 other
  7. Jul
    AlterGDebt · US$15MWith 1 other
  8. May
    LabcyteDebt · US$17MWith 1 other
  9. May
    Edgemont PharmaceuticalsDebt · USUndisclosedSole investor
  10. Apr
    Celula Inc.Debt · USUndisclosedSole investor
  11. Apr
    ReShape MedicalDebt · US$12MWith 1 other
  12. Jan
    InterValveDebt · US$3.0MSole investor
  13. Jan
    Minerva NeuroscienceDebt · US$15MWith 1 other
  14. 2014

    17 rounds

  15. Sept
    TransEnterixDebt · US$25MWith 1 other
  16. Sept
    PulmonxDebt · US$20MSole investor
  17. Aug
    diaDexusDebt · US$15MSole investor
  18. Aug
    Tarsa TherapeuticsDebt · US$10MWith 1 other
  19. Jul
    TrovaGeneDebt · US$15MWith 1 other
  20. Jul
    Cerus CorporationDebt · US$30MSole investor
  21. Jun
    Tobira TherapeuticsDebt · US$15MSole investor
  22. Jun
    IntellicytDebt · US$4.0MSole investor
  23. Apr
    Conventus OrthopaedicsDebt · US$10MWith 1 other
  24. Apr
    RF Surgical SystemsVenture · US$15MSole investor
  25. Apr
    SenseonicsDebt · US$10MSole investor
  26. Apr
    ZafgenDebt · US$20MWith 1 other
  27. Mar
    SonendoDebt · US$10MSole investor
  28. Mar
    Navidea BiopharmaceuticalsDebt · US$30MSole investor
  29. Mar
    OmerosDebt · US$32MWith 1 other
  30. Jan
    Proteus Digital HealthDebt · US$32MWith 1 other
  31. Jan
    Auspex PharmaceuticalsDebt · US$15MSole investor
  32. 2013

    9 rounds

  33. Dec
    Amicus TherapeuticsDebt · US$10MWith 2 others
  34. Dec
    Apollo EndosurgeryDebt · US$50MWith 3 others
  35. Dec
    CymaBay TherapeuticsDebt · US · bizjournals.com$5.0MWith 1 other
  36. Oct
    Monteris MedicalDebt · US · vcaonline.com$5.0MSole investor
  37. Sept
    SingulexDebt · US · finsmes.com$40MWith 1 other
  38. Aug
    PrimeSource Healthcare SystemsDebt · US · finsmes.com$5.5MSole investor
  39. Jul
    Continuum HealthcareDebt · US · pehub.com$12MSole investor
  40. Jul
    Cytori TherapeuticsDebt · US · socaltech.com$27MWith 2 others
  41. May
    CardioFocusDebt · US · finsmes.com$11MWith 1 other
  42. 2012

    5 rounds

  43. Sept
    CareDxDebt · US · pevc.dowjones.com$15MWith 1 other
  44. Jul
    LensARDebt · US · finsmes.com$10MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 23 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed9 in all

LensARBought by ALPHAEON Corporation$59MNov 2015
RF Surgical SystemsBought by Medtronic$235MJul 2015
Auspex PharmaceuticalsBought by Teva Pharmaceutical Industries$3.2BMar 2015
Avanir PharmaceuticalsBought by Otsuka Pharmaceutical$3.5BDec 2014
Ceptaris TherapeuticsBought by Actelion Pharmaceuticals$250MJul 2013
NanoString TechnologiesListed$54MJun 2013
BioVexBought by Amgen$1.0BJan 2011
ZogenixListedUndisclosedNov 2010
TengionListedUndisclosedApr 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Oxford Finance LLC. A count of rooms they were both in, not a relationship either has claimed.

SVB CapitalVC firm19rounds togetherMidCap FinancialPrivate credit4rounds togetherGE CapitalVC firm2rounds togetherSquare 1 BankInvestment firm2rounds together

Quick answers about Oxford Finance LLC

What does Oxford Finance LLC invest in?

Oxford Finance LLC invests most often at Debt and Venture (94% of the rounds on record), in sectors such as Well-being, Telehealth and Health-tech.

How active is Oxford Finance LLC?

53 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2015.

How big are Oxford Finance LLC's cheques?

The median round it joins is $15M. It says it writes cheques of $5.0M to $350M.

Does Oxford Finance LLC lead rounds?

Rarely, if at all: none of its 53 investments on record names it as the lead.

Where does Oxford Finance LLC invest?

Most of the companies it backs are in the United States (98%).

Is Oxford Finance LLC investing now?

No investments in the last 12 months; the latest was in Dec 2015.

Who does Oxford Finance LLC invest alongside?

Most often SVB Capital (19 rounds together), MidCap Financial (4 rounds together) and GE Capital (2 rounds together).

What kind of investor is Oxford Finance LLC?

Oxford Finance LLC is a private equity firm based in Alexandria, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it